ºë¯«½Ã¥Í¾÷ºc·j´M¾¹
·j´M"MOS - MOZ"¶}ÀY¤§¾÷ºc

1. Breakthrough Developments in Psychiatric Treatments October 26-27, 2007: New York, NY

The goal of this activity is to have participants begin to view etiology and diagnosis in terms of neurobiology of mental disorders as well as simply phenomenology. They will become more familiar with the latest advances in the neurobiology and be able to apply this information in developing treatment plans. They should incorporate such concepts into their clinical work and continue to do so for a significant period of time.

This course will highlight the latest advances in the neurobiology of the major mental disorders and link these advances to current and expected new treatments. Each major group of disorders will be addressed separately, first in terms of the neurobiology and etiology of the disorder, and then regarding treatments.

Objectives:

• Distinguish the latest diagnostic criteria for all major psychiatric disorders
• Define the neurobiological abnormalities underlying psychiatric disorders
• Apply neurobiological findings to planning treatments
• Assess and develop treatment plans including biological treatments that are consistent with the latest neurobiological and clinical research
• Identify the biological mechanisms of commonly used psychiatric treatments
• Integrate neurobiological and clinical research into developing biopsychosocial models of diagnosis and treatment

Program:

• Welcome and Course Overview
  • Eric Hollander, MD, Director, Seaver and NY Autism Center of Excellence; Esther and Joseph Klingenstein Professor and Chairman of Psychiatry, Mount Sinai School of Medicine, New York, New York (course co-director)
• Neurobiology and Treatment of Post Traumatic Stress Disorder
  • Rachel Yehuda, PhD, Director, Post Traumatic Stress Disorder Program, James J Peters VA Medical Center, Bronx; Director, Division of Traumatic Stress Studies; Professor of Psychiatry, Mount Sinai School of Medicine, New York, New York
• Breakthrough Treatments of Mood Disorders and Resiliency
  • Dennis S Charney, MD, Executive Vice President for Academic Affairs, The Mount Sinai Medical Center; Anne and Joel Ehrenkranz Professor, Departments of Psychiatry, Neuroscience, and Pharmacology & Systems Therapeutics; Dean, Mount Sinai School of Medicine, New York, New York
• Neurocognition and Neurobiology of Schizophrenia
  • Phil Harvey, PhD, Professor of Psychiatry and Behavioral Sciences and Psychology, Emory University, Atlanta, Georgia
• Mechanisms of Antipsychotics
  • James C Y Chou, MD, James J Peters VA Medical Center Bronx; Associate Clinical Professor, Department of Psychiatry, Mount Sinai School of Medicine, New York, New York (course co-director)
• Novel Approaches to Cognitive Enhancement in Alzheimer’s Disease
  • Mary Sano, PhD, Director of Research and Development, James J Peters VA Medical Center, Bronx; Director, Alzheimer Disease Research Center; Professor, Department of Psychiatry, Mount Sinai School of Medicine, New York, New York
• Treatments for Bipolar Disorder and Their Mechanisms
  • Joseph Goldberg, MD, Associate Clinical Professor of Psychiatry, Mount Sinai School of Medicine, New York, New York
• Mechanisms and Treatments of Anxiety
  • Sanjay Mathew, MD, Assistant Professor, Department of Psychiatry, Mount Sinai School of Medicine, New York, New York
• Breakthrough Treatments of Compulsive, Impulsive and Autistic Disorders
  • Eric Hollander, MD [see above]
• Research Update from the International Society for Research on Impulsivity
  • Eric Hollander, MD [see above]
  • Marc N Potenza, MD, PhD, Director of Neuroimaging, MIRECC VISN1, West Haven Veteran's Administration Hospital, New Haven; Associate Professor of Psychiatry, Yale University School of Medicine; Director, Problem Gambling Clinic at Yale; Director, Women and Addictions Core of Women's Health Research at Yale, New Haven, Connecticut
  • Alan C Swann, MD, Pat R Rutherford, Jr Chair in Psychiatry, Professor and Vice Chair for Research, Department of Psychiatry and Behavioral Sciences, University of Texas – Mental Sciences Institute, Houston
• Neurobiology and Treatment of Personality Disorders
  • Larry Siever, MD, Director of Mental Illness Research, Education Clinical Care (MIRECC); Chief of Mental Health, James J Peters VA Medical Center, Bronx; Professor of Psychiatry, Mount Sinai School of Medicine, New York, New York
• Functional Imaging in Personality Disorders
  • Harold W Koenigsberg, MD, James J Peters VA Medical Center Bronx; Associate Professor, Department of Psychiatry, Mount Sinai School of Medicine, New York, New York
• Translational Approaches to Addiction
  • Yasmin L Hurd, PhD, Professor, Department of Psychiatry; Professor, Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine New York, New York
• Optimizing Treatments for Substance Abuse
  • Harris B Stratyner, PhD, Vice President of New York Regional Services, Caron Treatment Center; Clinical Associate Professor, Department of Psychiatry, Mount Sinai School of Medicine, New York, New York